Clinical Trial Update: Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for neratinib in children and young adults with cancer, focusing on safety and dose finding in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Leukemia
• Lymphoma
• Solid Tumor

Drugs mentioned

• Neratinib (Nerlynx) (neratinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumor, Central Nervous System Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING